6063 Parvovirus B19 IgM

Intended Use:

The AESKULISA Parvovirus B19 IgM is a qualitative and quantitative immunoassay for the demonstration of human IgM antibodies in serum or plasma directed against Parvovirus B19. The AESKULISA Parvovirus B19 IgM is recommended for the detection of acute infections.

Recombinant Antigens:

Virus-like Particels (VLPs) composed of recombinant VP2 produced in baculovirus-infected insect cells

Native Antigens:


Kit Configuration

Method: Elisa
Reference: 6063
Description: Parvovirus B19 IgM
Kit Configuration: Single - M
Cut Off: 4-6
Range: 3 - 100 U/ml
Standard: -
Antibodies: IgM